PL-AC-328

N/A

Report date: 2023/09/25 13:58:05
NME

Base Information

Drug NamePL-AC-328
Drug Alias NamePL-AC-328
ClassificationSmall molecules
Mechanisms of ActionBradykinin receptors antagonists
TargetsBradykinin receptors
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPle Pharmacy (Jiangsu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPle Pharmacy (Jiangsu) Co Ltd
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A